GLP-1 and Intermittent Fasting for Pre-Diabetes Treatment
Unlocking a Powerful Synergy for Sustainable Weight Loss and Improved Metabolic Health
As the prevalence of pre-diabetes and type 2 diabetes continues to rise, researchers and healthcare professionals are exploring innovative approaches to prevent and manage these conditions. Two promising strategies that are gaining attention are GLP-1 (Glucagon-Like Peptide-1) medications and intermittent fasting. When combined, these two modalities can create a powerful synergy, leading to enhanced weight loss, improved metabolic health, and a reduced risk of developing type 2 diabetes.What are GLP-1 Medications?
